Difficulty: Medium
Average Score: 84%
Practice
A 13-year-old boy with moderate asthma presents to the clinic for follow-up. His symptoms appear to be better controlled since adding salmeterol to his regimen. He has had to use his rescue inhaler once over the past 2 weeks during exertion. His breathing at night has improved as well. How does salmeterol exhibit its beneficial effects for asthma?
Correct answer
D
Rationale
The correct answer is D) Long-acting ╬▓2-agonist.
Salmeterol is a long-acting ╬▓2-agonist, which means it acts on the ╬▓2-adrenergic receptors in the lungs to cause bronchodilation. By activating these receptors, salmeterol relaxes the smooth muscles in the airways, leading to improved breathing for patients with asthma.
Option A, Long-acting ╬▓1-agonist, is incorrect because salmeterol primarily acts on ╬▓2 receptors in the lungs, not ╬▓1 receptors.
Option B, Long-acting ╬▓1-antagonist, is incorrect because salmeterol is an agonist, not an antagonist.
Option C, Long-acting ╬▓1-and ╬▓2-agonist, is incorrect because salmeterol predominantly acts on ╬▓2 receptors rather than both ╬▓1 and ╬▓2 receptors.
Educationally, understanding the mechanism of action of different medications is crucial for healthcare professionals to make informed decisions about treatment options for patients with asthma. Knowing that salmeterol is a long-acting ╬▓2-agonist helps clinicians understand how this medication works to improve asthma symptoms and guides appropriate prescribing practices.
Salmeterol is a long-acting ╬▓2-agonist, which means it acts on the ╬▓2-adrenergic receptors in the lungs to cause bronchodilation. By activating these receptors, salmeterol relaxes the smooth muscles in the airways, leading to improved breathing for patients with asthma.
Option A, Long-acting ╬▓1-agonist, is incorrect because salmeterol primarily acts on ╬▓2 receptors in the lungs, not ╬▓1 receptors.
Option B, Long-acting ╬▓1-antagonist, is incorrect because salmeterol is an agonist, not an antagonist.
Option C, Long-acting ╬▓1-and ╬▓2-agonist, is incorrect because salmeterol predominantly acts on ╬▓2 receptors rather than both ╬▓1 and ╬▓2 receptors.
Educationally, understanding the mechanism of action of different medications is crucial for healthcare professionals to make informed decisions about treatment options for patients with asthma. Knowing that salmeterol is a long-acting ╬▓2-agonist helps clinicians understand how this medication works to improve asthma symptoms and guides appropriate prescribing practices.